CareDx, Inc. (CDNA) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGM. Market cap 3.22B USD. 52-week range 13.95 to 72.51 USD. Trailing P/E 29.9. Data as of 2026-10-09.
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also ...